300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Real Estate
Wine and Spirits
Mobile Apps
Finance
Sporting Goods
Manufacturing
FinTech
Social Media
Franchise
Music
Internet
Mobile Advertising
Android
Impact
Proptech
Art
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Faroe Islands
Argentina
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Oman
Zimbabwe
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Azerbaijan
Ethiopia
Jordan
Ecuador
Bahamas
Bahrain
Bulgaria
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Hungary
Italy
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Technion - Israel Institute of Technology, VC Fund

Technion - Israel Institute of Technology

VC Fund

Haifa, Israel

Technion - Israel Institute of Technology is a VC fund in Haifa focused on Medical and Health Care. “Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.

Total investments:
8
Last investment:
Lead investor:
13%

Last updated:

Industries Technion - Israel Institute of Technology invests in

MedicalHealth CareTherapeuticsBiotechnologyDrones

Stages Technion - Israel Institute of Technology invests in

SeedGrantSeries ASeries BVenture - Series Unknown

Countries Technion - Israel Institute of Technology invests in

IsraelUnited States

Round sizes

Seed $1.2M–$20M

Contacts

NameEmailPhoneSocials
See all 15 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1.2M–$20M

Investment Focus

Industry

  • Medical 3 (38%)
  • Health Care 3 (38%)
  • Therapeutics 2 (25%)
  • Biotechnology 2 (25%)
  • Drones 1 (13%)
See all 19 industries →

Stage

  • Seed 4 (50%)
  • Grant 1 (13%)
  • Series A 1 (13%)
  • Series B 1 (13%)
  • Venture - Series Unknown 1 (13%)

Country

  • Israel 4 (50%)
  • United States 2 (25%)

Team

NameTitleInvestmentsLinksEmail
Albert Einstein Founder
Founder Total investments: 0 Find email
Amichai Shulman
Amichai Shulman Adjunct Teacher
Adjunct Teacher Total investments: 6
Find email
Carmel Rotschild
Carmel Rotschild Senior Lecturer
Senior Lecturer Total investments: 0 Find email
Eyal S. Ron Mentor
Mentor Total investments: 0
Find email
Guy Yachdav
Guy Yachdav Lecturer on Machine Learning
Lecturer on Machine Learning Total investments: 0 Find email
See all 15 team members →

Investments

CompanyDescriptionRoundLinks
Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients. $2.2M / Seed / Nov 24, 2025
Mana.bio develops artificial intelligence–based platforms for drug delivery using lipid nanoparticles (LNPs). The company combines machine learning with nanotechnology to design, test, and refine LNP formulations through computational modeling and laboratory validation. Its technology focuses on extrahepatic tissue targeting and includes researchon lung-targeted delivery and safety improvements through predictive modeling. Mana.bio has introduced ChatLNP, a tool that supports literature analysis, property prediction, and formulation optimization. The platform integrates experimental results with public data to enhance model accuracy and broaden its design capabilities for gene therapy and RNA-based medicines. $19.5M / Seed / Oct 10, 2023
ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotechexperience. $4.3M / Venture - Series Unknown / Jun 09, 2021
Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel. $2.7M / Seed / May 24, 2021
Regulus provides affordable GNSS spoofing detection and protection to the mass markets requiring reliability and low-cost. The Pyramid Software technology defends against ever-increasing attacks and interferences.The Regulus Pyramid GNSS technology provides revolutionary tools to defend against GNSS/GPS spoofing attacks for automotive,mobile, maritime, aviation, critical infrastructure and various other applications, markets and users. *(GNSS = Global Navigation Satellite Systems: GPS, BeiDou, Galileo, Glonass, and more.) $4M / Series B / May 18, 2020
The University of Michigan offers a broad spectrum of academic programs and research opportunities across 19 schools and colleges, encompassing over 275 degree programs. The institution emphasizes interdisciplinary collaboration, integrating fields such as engineering, business, medicine, and the arts. Research initiatives address diverse topics, including electric vehicle charging technologies, environmental sustainability, and public health. The university's commitment to sustainability is evident through campus-wide initiatives that engage students, faculty, and staff. Additionally, the institution focuses on diversity, equity, and inclusion, providing resources and programs to support first-generation students and underrepresented communities. Through its comprehensive educational offerings and research endeavors, University of Michigan contributes to various academic and societal advancements. $20M / Grant / Oct 16, 2018
Regulus provides affordable GNSS spoofing detection and protection to the mass markets requiring reliability and low-cost. The Pyramid Software technology defends against ever-increasing attacks and interferences.The Regulus Pyramid GNSS technology provides revolutionary tools to defend against GNSS/GPS spoofing attacks for automotive,mobile, maritime, aviation, critical infrastructure and various other applications, markets and users. *(GNSS = Global Navigation Satellite Systems: GPS, BeiDou, Galileo, Glonass, and more.) $5.1M / Series A / Apr 26, 2018
Regulus provides affordable GNSS spoofing detection and protection to the mass markets requiring reliability and low-cost. The Pyramid Software technology defends against ever-increasing attacks and interferences.The Regulus Pyramid GNSS technology provides revolutionary tools to defend against GNSS/GPS spoofing attacks for automotive,mobile, maritime, aviation, critical infrastructure and various other applications, markets and users. *(GNSS = Global Navigation Satellite Systems: GPS, BeiDou, Galileo, Glonass, and more.) $1.2M / Seed / Apr 26, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Real Estate
Wine and Spirits
Mobile Apps
Finance
Sporting Goods
Manufacturing
FinTech
Social Media
Franchise
Music
Internet
Mobile Advertising
Android
Impact
Proptech
Art
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Faroe Islands
Argentina
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Oman
Zimbabwe
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Azerbaijan
Ethiopia
Jordan
Ecuador
Bahamas
Bahrain
Bulgaria
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Hungary
Italy
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Technion - Israel Institute of Technology invest in?

Technion - Israel Institute of Technology invests primarily in Medical, Health Care and Therapeutics startups, most often at Seed and Grant stage. Most of the 8 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Technion - Israel Institute of Technology invest in?

Technion - Israel Institute of Technology typically joins rounds of $1.2M–$20M at Seed. These are whole funding-round sizes, not Technion - Israel Institute of Technology's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Technion - Israel Institute of Technology took part in.

How do I contact Technion - Israel Institute of Technology?

Public channels for Technion - Israel Institute of Technology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Technion - Israel Institute of Technology?

The team at Technion - Israel Institute of Technology includes Albert Einstein (Founder), Amichai Shulman (Adjunct Teacher) and Carmel Rotschild (Senior Lecturer), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Technion - Israel Institute of Technology Technion - Israel Institute of Technology Find emails